ReNAgade Therapeutics

ReNAgade Therapeutics

Revolutionizing RNA medicine with integrated delivery, coding, editing, and insertion technologies to precisely correct diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€1.1—1.6b (Dealroom.co estimates May 2023.)
Cambridge Massachusetts (HQ)
Authorizing premium user...